|
1
|
Novaes FT, Cataneo DC, Ruiz RL Jr, et al:
Lung cancer: histology, staging, treatment and survival. J Bras
Pneumol. 34:595–600. 2008.In English and Portuguese. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas L, Doyle LA and Edelman MJ: Lung
cancer in women: emerging differences in epidemiology, biology, and
therapy. Chest. 128:370–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Novello S and Vavalà T: Lung cancer and
women. Future Oncol. 4:705–716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Devesa SS, Bray F, Vizcaino AP, et al:
International lung cancer trends by histologic type: male:female
differences diminishing and adenocarcinoma rates rising. Int J
Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Egleston BL, Meireles SI, Flieder DB, et
al: Population-based trends in lung cancer incidence in women.
Semin Oncol. 36:506–515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ondrusova M, Muzik J, Hunakova L, et al:
Trends in the lung cancer incidence and mortality in the Slovak and
Czech Republics in the contexts of an international comparison.
Clin Transl Oncol. 14:659–666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eilstein D and Eshai K: Lung and breast
cancer mortality among women in France: future trends. Cancer
Epidemiol. 36:e341–e348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thompson CA, Waldhör T, Schernhammer ES,
et al: Smoking and lung cancer: current trends in Austria. Wien
Klin Wochenschr. 124:493–499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Youlden DR, Cramb SM and Baade PD: The
international epidemiology of lung cancer: geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malvezzi M, Bertuccio P, Levi F, et al:
European cancer mortality predictions for the year 2012. Ann Oncol.
23:1044–1052. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stahel RA: Adenocarcinoma, a molecular
perspective. Ann Oncol. 18(Suppl 9): 147–149. 2007. View Article : Google Scholar
|
|
12
|
Kadara H, Kabbout M and Wistuba II:
Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology.
17:50–65. 2012. View Article : Google Scholar
|
|
13
|
Li J, Chen P, Li XQ, et al: Elevated
levels of survivin and livin mRNA in bronchial aspirates as markers
to support the diagnosis of lung cancer. Int J Cancer.
132:1098–1104. 2013. View Article : Google Scholar
|
|
14
|
Hartman ML and Czyz M: Anti-apoptotic
proteins on guard of melanoma cell survival. Cancer Lett.
331:24–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye L, Song X, Li S, et al: Livin-α
promotes cell proliferation by regulating G1-S cell cycle
transition in prostate cancer. Prostate. 71:42–51. 2012. View Article : Google Scholar
|
|
16
|
Guo H, Gao YT, Zhang Q, et al: Expression
and clinical significance of livin protein in hepatocellular
carcinoma. Dis Markers. 35:489–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bavykin AS, Korotaeva AA, Poyarkov SV, et
al: Double siRNA-targeting of cIAP2 and LIVIN results in synergetic
sensitization of HCT-116 cells to oxaliplatin treatment. Onco
Targets Ther. 6:1333–1340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu M, Xia LP, Fan LJ, et al: Livin and
caspase-3 expression are negatively correlated in cervical squamous
cell cancer. Eur J Gynaecol Onco. l34:152–155. 2013.
|
|
19
|
Li F, Yin X, Luo X, et al: Livin promotes
progression of breast cancer through induction of
epithelial-mesenchymal transition and activation of AKT signaling.
Cell Signal. 25:1413–1422. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dasgupta A, Alvarado CS, Xu Z, et al:
Expression and functional role of inhibitor-of-apoptosis protein
livin (BIRC7) in neuroblastoma. Biochem Biophys Res Commun.
400:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gazzaniga P, Gradilone A, Giuliani L, et
al: Expression and prognostic significance of LIVIN, SURVIVIN and
other apoptosis-related genes in the progression of superficial
bladder cancer. Ann Oncol. 14:85–90. 2003. View Article : Google Scholar
|
|
22
|
Xi RC, Sheng YR, Chen WH, et al:
Expression of survivin and livin predicts early recurrence in
non-muscle invasive bladder cancer. J Surg Oncol. 107:550–554.
2013. View Article : Google Scholar
|
|
23
|
Tanabe H, Yagihashi A, Tsuji N, et al:
Expression of survivin mRNA and livin mRNA in non-small-cell lung
cancer. Lung Cancer. 46:299–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang Y, Yao H, Wang S, et al: Prognostic
value of Survivin and Livin in nasopharyngeal carcinoma.
Laryngoscope. 116:126–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kempkensteffen C, Hinz S, Christoph F, et
al: Expression of the apoptosis inhibitor livin in renal cell
carcinomas: correlations with pathology and outcome. Tumor Biol.
28:132–138. 2007. View Article : Google Scholar
|
|
26
|
Augello C, Caruso L, Maggioni M, et al:
Inhibitors of apoptosis proteins (IAPs) expression and their
prognostic significance in hepatocellular carcinoma. BMC Cancer.
9:1252009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xi RC, Biao WS and Gang ZZ: Significant
elevation of survivin and livin expression in human colorectal
cancer: inverse correlation between expression and overall
survival. Onkologie. 34:428–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lazar I, Perlman R, Lotem M, et al: The
clinical effect of the inhibitor of apoptosis protein livin in
melanoma. Oncology. 82:197–204. 2012. View Article : Google Scholar
|
|
29
|
Li X, Fan S, Li L, et al: RNA
interference-mediated knockdown of Livin suppresses cell
proliferation and invasion and enhances the chemosensitivity to
cisplatin in human osteosarcoma cells. Int J Oncol. 43:159–168.
2013.PubMed/NCBI
|
|
30
|
Liang YZ, Fang TY, Xu HG, et al:
Expression of CD44v6 and Livin in gastric cancer tissue. Chin Med J
(Engl). 125:3161–3165. 2012.
|
|
31
|
Choi J, Hwang YK, Sung KW, et al:
Expression of Livin, an antiapoptotic protein, is an independent
favorable prognostic factor in childhood acute lymphoblastic
leukemia. Blood. 109:471–477. 2007. View Article : Google Scholar
|
|
32
|
Nedelcu T, Kubista B, Koller A, et al:
Livin and Bcl-2 expression in high-grade osteosarcoma. J Cancer Res
Clin Oncol. 134:237–244. 2008. View Article : Google Scholar
|
|
33
|
Yang YL, Lin SR, Chen JS, et al:
Expression and prognostic significance of the apoptotic genes
BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic
leukemia. Leuk Res. 34:18–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu HB, Kong CZ, Zeng Y, et al: Livin may
serve as a marker for prognosis of bladder cancer relapse and a
target of bladder cancer treatment. Urol Oncol. 27:277–283. 2009.
View Article : Google Scholar
|
|
35
|
Wang X, Xu J, Ju S, et al: Livin gene
plays a role in drug resistance of colon cancer cells. Clin
Biochem. 43:655–660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun JG, Liao RX, Zhang SX, et al: Role of
inhibitor of apoptosis protein Livin in radiation resistance in
nonsmall cell lung cancer. Cancer Biother Radiopharm. 26:585–592.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Crnković-Mertens I, Muley T, Meister M, et
al: The anti-apoptotic livin gene is an important determinant for
the apoptotic resistance of non-small cell lung cancer cells. Lung
Cancer. 54:135–142. 2006. View Article : Google Scholar
|
|
38
|
Chang H and Schimmer AD: Livin/melanoma
inhibitor of apoptosis protein as a potential therapeutic target
for the treatment of malignancy. Mol Cancer Ther. 6:24–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Crnković-Mertens I, Wagener N, Semzow J,
et al: Targeted inhibition of Livin resensitizes renal cancer cells
towards apoptosis. Cell Mol Life Sci. 64:1137–1144. 2007.
View Article : Google Scholar
|
|
40
|
Liu B, Han M, Wen JK, et al: Livin/ML-IAP
as a new target for cancer treatment. Cancer Lett. 250:168–176.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Abd-Elrahman I, Hershko K, Neuman T, et
al: The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual
role in tumorigenicity. Cancer Res. 69:5475–5480. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu L and Wang Z: Effects of Livin gene RNA
interference on apoptosis of cervical cancer HeLa cells and
enhanced sensitivity to cisplatin. J Huazhong Univ Sci Technolog
Med Sci. 29:625–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang TS, Ding QQ, Guo RH, et al:
Expression of livin in gastric cancer and induction of apoptosis in
SGC-7901 cells by shRNA-mediated silencing of livin gene. Biomed
Pharmacother. 64:333–338. 2010. View Article : Google Scholar
|
|
44
|
Yang D, Song X, Zhang J, et al:
Therapeutic potential of siRNA-mediated combined knockdown of the
IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24
cells. Acta Biochim Biophys Sin (Shanghai). 42:137–144. 2010.
View Article : Google Scholar
|
|
45
|
Yang D, Song X, Zhang J, et al:
Suppression of livin gene expression by siRNA leads to growth
inhibition and apoptosis induction in human bladder cancer T24
cells. Biosci Biotechnol Biochem. 74:1039–1044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu H, Wang S, Sun H, et al: Inhibition of
tumorigenesis and invasion of hepatocellular carcinoma by
siRNA-mediated silencing of the livin gene. Mol Med Rep. 3:903–907.
2010.
|
|
47
|
Yuan B, Ran B, Wang S, et al: siRNA
directed against Livin inhibits tumor growth and induces apoptosis
in human glioma cells. J Neurooncol. 107:81–87. 2012. View Article : Google Scholar
|
|
48
|
Chen F, Yang D, Wang S, et al: Livin
regulates prostate cancer cell invasion by impacting the NF-κB
signaling pathway and the expression of FN and CXCR4. IUBMB Life.
64:274–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu X, Wang A, Gao H, et al: Expression
and role of the inhibitor of apoptosis protein livin in
chemotherapy sensitivity of ovarian carcinoma. Int J Oncol.
41:1021–1028. 2012.PubMed/NCBI
|
|
50
|
Wang XT, Xie YB and Xiao Q: siRNA
targeting of Cdx2 inhibits growth of human gastric cancer MGC-803
cells. World J Gastroenterol. 18:1903–1914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ou JM, Ye B, Qiu MK, et al: Knockdown of
Livin inhibits growth and invasion of gastric cancer cells through
blockade of the MAPK pathway in vitro and in vivo. Int J Oncol.
44:276–284. 2014.
|
|
52
|
Trinh DT, Shibata K, Hirosawa T, et al:
Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and
glypican-3 in malignant germ cell tumors of the ovary. J Obstet
Gynaecol Res. 38:841–848. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jin T, Branch DR, Zhang X, et al:
Examination of POU homeobox gene expression in human breast cancer
cells. Int J Cancer. 81:104–112. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
He YQ, Zhuang li, Liu SY, et al: Mechanism
of the apoptosis induction by Flavopiridol synergizes TRAIL in
SPC-A1 cell. Chinese Journal of Cancer Prevention and Treatment.
20:730–733. 2013.In Chinese.
|
